ARCHIVES

Totality Of Evidence Causes Concern About New Findings.

This article is from The Cancer Letter archive.

Vol. 33 No. 45 | December 7, 2007

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

NCI To Fund Two Construction Grants With 42 Million From Special NIH Fund

March 2, 1990

ASCO Objects To Proposed Graduate Medical Education Bill

September 20, 1985

Foon To Direct Barrett Center; Hundahl Leads Commission

March 5, 1999

In Brief: ACS Board Names McGinnis Prsident; Fuller Re-Elected chairman; Lenhard Is Vice President

November 25, 1994

Next Bypass Budget: Slim, Trim, Modest

September 15, 1995